Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Vareda, Priscilla Maria Ponce ^a   Saldanha, Luiz Leonardo ^a   Camaforte, Nathalia Aparecida De Paula ^a   Violato, Natalia Moretti ^a   Dokkedal, Anne Lígia ^a   Bosqueiro, José Roberto ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ALCOHOL; ANTIDIABETIC AGENT; CHOLESTEROL; FLAVONOID GLYCOSIDE; GLUCOSE; GLYCOGEN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MYRCIA BELLA LEAF EXTRACT; MYRICETIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN; PROTEIN KINASE B; QUERCETIN; SODIUM CHLORIDE; STREPTOZOCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; INSULIN BLOOD LEVEL; MALE; MEDICINAL PLANT; MOUSE; MOUSE MODEL; MYRCIA BELLA; NONHUMAN; PLANT LEAF; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REDUCTION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84901269543     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/543606     Document Type: Article

References (31)

1. American Diabetes Association, Diagnosis and classification of Diabetes mellitus. Diabetes Care 2011 34 supplement 1 S62 S69 10.2337/dc11-S062
2. Sociedade Brasileira de Diabetes (SBD),. Diretrizes da Sociedade Brasileira de Diabetes, 2009, http://www.diabetes.org.br/attachments/ diretrizes09-final.pdf
3. Cheng A. Y. Y., Fantus I. G., Oral antihyperglycemic therapy for type 2 Diabetes mellitus. Canadian Medical Association Journal 2005 172 2 213 226 2-s2.0-12444289448 10.1503/cmaj.1031414
4. Grover J. K., Yadav S., Vats V., Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002 81 1 81 100 2-s2.0-0036000246 10.1016/S0378-8741(02)00059-4 (Pubitemid 34518472)
5. Kumar A., Ilavarasan R., Jayachandra T., Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. Journal of Medicinal Plants Research 2008 2 9 246 249
6. Wilson P. G., O'Brien M. M., Gadek P. A., Quinn C. J., Myrtaceae revisited: a reassessment of infrafamilial groups. American Journal of Botany 2001 88 11 2013 2025 2-s2.0-0000405522 (Pubitemid 33649781)
7. De Cerqueira M. D., De Marques E. J., Martins D., Roque N. F., Cruz F. G., Guedes M. L. D. S., Seasonal variation of the composition of essential oil from Myrcia salzmannii berg. (myrtaceae). Quimica Nova 2009 32 6 1544 1548 2-s2.0-70349915793
8. Russo E. M., Reichelt A. A., De-Sa J. R., Furlanetto R. P., Moises R. C. S., Kasamatsu T. S., Chacra A. R., Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Brazilian Journal of Medical and Biological Research 1990 23 1 11 20 2-s2.0-0025159388 (Pubitemid 20081609)
9. Hashimoto G., Illustrated Cyclopedia of Brazilian Medicinal Plants 1996 Kamakura, Japan Aboc-Sha
10. Jorge L. I. F., Aguiar J. P. L., Silva M. L., Anatomia foliar de pedra-hume-caá (Myrcia sphaerocarpa, Myrcia guianensis, Eugia punicifolia-Myrtaceae). Acta Amazonica 2000 30 49 57
11. Yoshikawa M., Shimada H., Nishida N., Li Y., Toguchida I., Yamahara J., Matsuda H., Antidiabetic principles of natural medicines. lI. Aldose reductase and α -glucosidase inhibitors from brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B. Chemical and Pharmaceutical Bulletin 1998 46 1 113 119 2-s2.0-0031887718 (Pubitemid 28099435)
12. Limberger R. P., Sobral M., Henriques A. T., Menut C., Bessière J., Essential oils from Myrcia species native to Rio Grande do Sul. Quimica Nova 2004 27 6 916 919 2-s2.0-30744478968 (Pubitemid 43092924)
13. Matsuda H., Morikawa T., Yoshikawa M., Antidiabetogenic constituents from several natural medicines. Pure and Applied Chemistry 2002 74 7 1301 1308 2-s2.0-0036664538
14. Matsuda H., Nishida N., Yoshikawa M., Antidiabetic principles of natural medicines. V. Aldose reductase inhibitors from Myrcia multiflora DC. (2): structures of myrciacitrins III, IV, and V. Chemical and Pharmaceutical Bulletin 2002 50 3 429 431 2-s2.0-0036511915 10.1248/cpb.50.429 (Pubitemid 41685653)
15. Saldanha L. L., Vilegas W., Dokkedal A. L., Characterization of flavonoids and phenolic acids in Myrcia bella Cambess. Using FIA-ESI-IT-MSn and HPLC-PAD-ESI-IT-MS combined with NMR. Molecules 2013 18 7 8402 8416 10.3390/molecules18078402
16. Brito A. S., Manual de Ensaios Toxicológicos 1995 Campinas, Brazil Ciências Médicas
17. Rafacho A., Roma L. P., Taboga S. R., Boschero A. C., Bosqueiro J. R., Dexamethasone-induced insulin resistance is associated with increased connexin 36 mRNA and protein expression in pancreatic rat islets. Canadian Journal of Physiology and Pharmacology 2007 85 5 536 545 2-s2.0-34548173724 10.1139/Y07-037 (Pubitemid 47309800)
18. Szkudelski T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research 2001 50 6 537 546 2-s2.0-0035691617 (Pubitemid 34087272)
19. Pepato M. T., Oliveira J. R., Kettelhut I. C., Migliorini R. H., Assessment of the antidiabetic activity of Myrcia uniflora extracts in streptozotocin diabetic rats. Diabetes Research 1993 22 2 49 57 2-s2.0-0027828746
20. Middleton E. Jr., Kandaswami C., Theoharides T. C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000 52 4 673 751 2-s2.0-0033637140
21. Ong K. C., Khoo H., Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sciences 2000 67 14 1695 1705 2-s2.0-0034714436 10.1016/S0024-3205(00)00758-X
22. Vessal M., Hemmati M., Vasei M., Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comparative Biochemistry and Physiology-C Toxicology and Pharmacology 2003 135 3 357 364 2-s2.0-0041589462 10.1016/S1532-0456(03)00140-6 (Pubitemid 36962949)
23. Liu I.-M., Liou S., Lan T., Hsu F., Cheng J., Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Medica 2005 71 7 617 621 2-s2.0-23644438869 10.1055/s-2005-871266 (Pubitemid 41133070)
24. Qi L. W., Liu E.-H., Chu C., Peng Y., Cai H., Li P., Anti-diabetic agents from natural products-an update from 2004 to 2009. Current Topics in Medicinal Chemistry 2010 10 4 434 457 2-s2.0-77949452664 10.2174/156802610790980620
25. Jung M., Park M., Lee H. C., Kan Y., Kang E. S., Kim S. K., Antidiabetic agents from medicinal plants. Current Medicinal Chemistry 2006 13 10 1203 1218 2-s2.0-33645979959 10.2174/092986706776360860
26. Jiang C. S., Liang L. F., Guo Y. W., Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacologica Sinica 2012 33 1217 1245 10.1038/aps.2012.90
27. Carvalheira J. B. C., Zecchin H. G., Saad M. J. A., Insulin signaling pathways. Arquivos Brasileiros de Endocrinologia & Metabologia 2002 46 4 419 425 10.1590/S0004-27302002000400013
28. Lehto S., Rönnemaa T., Haffner S. M., Pyörälä K., Kallio V., Laakso M., Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997 46 8 1354 1359 2-s2.0-1842301672 (Pubitemid 27315286)
29. Rahman K., Studies on free radicals, antioxidants, and co-factors. Clinical Interventions in Aging 2007 2 2 219 236 2-s2.0-38449121513
30. Dornas W. C., Oliveira T. T., Rodrigues-das-Dores R. G., Santos A. F., Nagem T. J., Flavonoids: therapeutic potential against oxidative stress. Revista de Ciencias Farmaceuticas Basica e Aplicada 2007 28 3 241 249 2-s2.0-50049105510
31. Wang C. G., Mehendale S. R., Calway T., Yuan C. S., Botanical flavonoids on coronary heart disease. American Journal of Chinese Medicine 2011 39 4 661 671 2-s2.0-79959926613 10.1142/S0192415X1100910X